Track Daiichi Sankyo Company, Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Daiichi Sankyo Company, Limited 4568.T · Stock Open Daiichi Sankyo Company, Limited in new tab

2857.50 JPY
P/E
18.29
EPS
153.05
Yield
3.08%
Safety Score
50
P/B
2.90
ROE
17.59
Beta
-0.11
Target Price
4021.25 JPY
Loading chart...
Key Metrics
Earnings dateJan. 29, 2027
P/E18.29
EPS153.05
Book Value964.65
Price to Book2.90
Debt/Equity28.11
% Insiders0.174%
Growth
Revenue Growth0.18%
Earnings Growth0.86%
Estimates
Forward P/E19.50
Forward EPS143.56
Target Mean Price4021.25
Dividend
Dividend Yield3.08%
Annual dividends89.00 JPY
Ex-Div. DateMarch 30, 2027
Payout50.87%
5y avg Yield1.33%

DCF valuation

Model fair value for Daiichi Sankyo Company, Limited (4568.T)
Result
Sign in to run the valuation for 4568.T.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
16 analysts · consensus Strong buy · mean target 4021.25 JPY (low 2750.00, high 5200.00) · as of 10 Nov 2026
Low 2750.00
Mean 4021.25
High 5200.00
Price 2857.50
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Daiichi Sankyo Company, Limited Logo Daiichi Sankyo Company, Limited Analysis (4568.T)

Japan Health Care Official Website Stock

Is Daiichi Sankyo Company, Limited a good investment? Daiichi Sankyo Company, Limited (4568.T) is currently trading at 2857.50 JPY. Market analysts have a consensus price target of 4021.25 JPY. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 18.29. This valuation is generally in line with the broader market.

Earnings Schedule: Daiichi Sankyo Company, Limited is expected to release its next earnings report on Jan. 29, 2027. The market consensus estimate for Forward EPS is 143.56.

For income investors, Daiichi Sankyo Company, Limited pays a dividend yield of 3.08%. With a payout ratio of 51%, the dividend appears sustainable.

Investor FAQ

Does Daiichi Sankyo Company, Limited pay a dividend?

Yes, it pays an annual dividend of 89.00 JPY (3.08% yield).

What asset class is Daiichi Sankyo Company, Limited?

Daiichi Sankyo Company, Limited is classified as a Stock. You can compare it against 4 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Jan. 29, 2027. The company currently has a trailing EPS of 153.05.

Company Profile

Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan and internationally. The company offers Enhertu for the treatment of HER2 positive and low breast cancer, HER2 positive gastric or gastroesophageal junction adenocarcinoma, and HER2 positive solid tumors; Turalio, an oral small molecule for colony stimulating factor 1 receptor, KIT proto-oncogene receptor tyrosine kinase, and FMS-like tyrosine kinase 3, as well as symptomatic TGCT; Vanflyta, a FLT3 inhibitor for the treatment of acute myeloid leukemia; Injectafer, a ferric carboxymaltose injection for the treatment of iron deficiency; and Datroway for the treatment of HR positive and HER2 negative breast cancer, as well as NSCLC. It also provides Lixiana and Savaysa, which are direct factor Xa inhibitors; Minnebro, Olmetec, Olmetec Plus, Rezaltas, Sevikar, and Sevikar HCT, which are antihypertensive agents; Nilemdo that lowers cholesterol; Nustendi, a fixed-dose combination tablet of bempedoic acid and ezetimibe that reduces cholesterol; and Efient, an anti-platelet agent. In addition, the company offers Canalia for the treatment of type 2 diabetes mellitus; Emgality for the treatment of migraine attacks; Pralia for the treatment of osteoporosis and bone erosion associated with rheumatoid arthritis; Ranmark for the treatment of bone complications and GCTB; Tarlige for the treatment of neuropathic pain; Venofer for the treatment of iron deficiency anemia; Vimpat, an anti-seizure medication; and Reyvow for the treatment of acute migraine attacks. Further, it provides Daichirona, a coronavirus RNA vaccine; Flumist, an intranasal live attenuated influenza vaccine; adsorbed cell culture-derived influenza vaccine; measles rubella combined vaccine; and mump vaccine. The company was formerly known as Sankyo Co. Ltd. and changed its name to Daiichi Sankyo Company, Limited in September 2005. Daiichi Sankyo Company, Limited was founded in 1899 and is headquartered in Chuo, Japan.

Exchange Ticker
D4S.SG
JPX (Japan) 4568.T
PNK (United States) DSKYF
FRA (Germany) D4S.F
Trades
Dividend Yield
3.08%
5y avg 1.33%
Annual Dividends
89.00JPY
Next Ex. Div Date
March 30, 2027
Payout Ratio
50.87%
Dividend History paid per year (JPY)
Historical Dividends
Year Total Dividends
▸2027
50.00 JPY
June 23, 2027 50.0000
▸2026
89.00 JPY
Dec. 10, 2026 50.0000
June 23, 2026 39.0000
▸2025
69.00 JPY
Dec. 10, 2025 39.0000
June 24, 2025 30.0000
▸2024
60.00 JPY
Dec. 10, 2024 30.0000
June 18, 2024 30.0000
▸2023
35.00 JPY
Dec. 8, 2023 20.0000
June 20, 2023 15.0000
▸2022
27.00 JPY
Dec. 1, 2022 13.5000
June 28, 2022 13.5000
▸2021
27.00 JPY
Dec. 1, 2021 13.5000
June 22, 2021 13.5000
▸2020
75.50 JPY
Dec. 1, 2020 40.5000
June 16, 2020 35.0000
▸2019
70.00 JPY
Dec. 2, 2019 35.0000
June 18, 2019 35.0000
▸2018
70.00 JPY
Dec. 3, 2018 35.0000
June 19, 2018 35.0000
▸2017
70.00 JPY
Dec. 1, 2017 35.0000
June 20, 2017 35.0000
▸2016
65.00 JPY
Sept. 28, 2016 35.0000
March 29, 2016 30.0000
▸2015
40.00 JPY
Sept. 28, 2015 10.0000
March 27, 2015 30.0000
▸2014
60.00 JPY
Sept. 26, 2014 30.0000
March 27, 2014 30.0000
▸2013
60.00 JPY
Sept. 26, 2013 30.0000
March 27, 2013 30.0000
▸2012
60.00 JPY
Sept. 26, 2012 30.0000
March 28, 2012 30.0000
▸2011
60.00 JPY
Sept. 28, 2011 30.0000
March 29, 2011 30.0000
▸2010
60.00 JPY
Sept. 28, 2010 30.0000
March 29, 2010 30.0000
▸2009
70.00 JPY
Sept. 25, 2009 30.0000
March 26, 2009 40.0000
▸2008
75.00 JPY
Sept. 25, 2008 40.0000
March 26, 2008 35.0000
▸2007
65.00 JPY
Sept. 25, 2007 35.0000
March 27, 2007 30.0000
▸2006
55.00 JPY
Sept. 26, 2006 30.0000
March 28, 2006 25.0000
▸2005
75.00 JPY
March 28, 2005 75.0000
▸2004
22.50 JPY
Sept. 27, 2004 15.0000
March 26, 2004 7.5000
▸2003
20.00 JPY
Sept. 25, 2003 10.0000
March 26, 2003 10.0000
▸2002
15.00 JPY
Sept. 25, 2002 12.5000
March 26, 2002 2.5000
▸2001
14.75 JPY
Sept. 25, 2001 2.5000
March 27, 2001 12.2500
▸2000
24.50 JPY
Sept. 26, 2000 12.2500
March 28, 2000 12.2500
Upcoming Dividends
Name Payment Date Status Amount
Daiichi Sankyo Company, Limited Jun 23, 2027 Upcoming 50.0 JPY
Daiichi Sankyo Company, Limited Dec 10, 2026 Upcoming 50.0 JPY
Daiichi Sankyo Company, Limited Jun 23, 2026 39.0 JPY
Stock Splits
Split Date Split Ratio to 1
Sept. 29, 2020 3:1
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion